pellucid marginal degeneration bellingham

The center of the cornea shows normal thickness, with an intact central epithelium, but the inferior cornea exhibits a peripheral band of thinning, to about 1–2 mm. The Bowman's layer of the cornea may be absent, irregular, or have ruptured areas. There may be an increase in the number of mucopolysaccharides in the corneal stroma. The thinning of the corneas may approach 20% of normal thickness. PMD is an idiopathic, non-inflammatory condition. Normally, PMD does not present with vascularization of the cornea, scarring, or any deposits of lipid. This is described as a 'beer belly' appearance since the greatest protrusion occurs below the horizontal midline (unlike keratoconus). The cornea just above the region of thinning is of normal thickness, and may protrude anteriorly, which creates an irregular astigmatism. The distribution of the degeneration is crescent or arcuate shaped. PMD is characterized by bilateral thinning ( ectasia) in the inferior and peripheral region of the cornea. While PMD usually affects both eyes, some unilateral cases have been reported. However, in rare cases, PMD may present with sudden onset vision loss and excruciating eye pain, which occurs if the thinning of the cornea leads to perforation. Pain is not typically present in pellucid marginal degeneration, and aside from vision loss, no symptoms accompany the condition. The condition is rare, though the exact prevalence and incidence are unknown. The word 'pellucid' means clear, indicating that the corneas retain clarity in pellucid marginal degeneration.

The term 'pellucid marginal degeneration' was first coined in 1957 by the ophthalmologist Schalaeppi. Surgery is reserved for individuals who do not tolerate contact lenses. Intacs implants, corneal collagen cross-linking, and corneal transplant surgery are additional options. Treatment usually consists of vision correction with eyeglasses or contact lenses. Corneal pachymetry may be useful in confirming the diagnosis. Pellucid marginal degeneration is diagnosed by corneal topography. The cause of the disease remains unclear.

It is typically characterized by a clear, bilateral thinning ( ectasia) in the inferior and peripheral region of the cornea, although some cases affect only one eye. Rarely, it may cause acute vision loss with severe pain due to perforation of the cornea. It typically presents with painless vision loss affecting both eyes. Pellucid marginal degeneration ( PMD) is a degenerative corneal condition, often confused with keratoconus. Vision correction ( eyeglasses or contact lenses) Pellucid corneal degeneration with hydrops and detachment of Descemet's membrane Stability of astigmatism, keratometric parameters and improvement in BCVA in our study indicates the efficacy of CXL to prevent progression in PMD.Medical condition Pellucid marginal degeneration Collagen cross linking is a safe and effective method to prevent progression in PMD. None of the treated eyes developed side effect of notable severity. Keratometric astigmatism decreased by 1.13 D (P = 0.2) measured by Scheimpflug imaging and by 1.4 D (P = 0.13) as measured by topography. There was no significant difference in the pre and post-op spherical equivalent (P = 0.38) and the mean cylinder decreased by 0.53 ± 0.81 D (P = 0.19) which was not significant. logMAR UCVA (uncorrected visual acuity) and BCVA (best corrected visual acuity) with spectacles at 6 months and at final follow-up showed improvement in all groups, which were significant in group C. Visual acuity, retinoscopic refraction, corneal topography, tomography and pachymetry were examined before and every six months after surgery for the first two years and then annually. The eyes were divided as per riboflavin used namely hypo-osmolar, HPMC (hydroxy propyl methyl cellulose), iso-osmolar into group A, B and C respectively. A retrospective interventional study involving 15 eyes of 10 patients with pellucid marginal degeneration (PMD) were treated with collagen cross linking (CXL) to evaluate itslong term effects on such patients.

Pellucid marginal degeneration bellingham